Citation: Vj. Dzau, PRESENTATION OF THE 1998 KOBER-MEDAL TO BRAUNWALD,EUGENE, Proceedings of the Association of American Physicians, 110(5), 1998, pp. 445-450
Citation: Dy. Lin et al., THE ROLE OF INSULIN-RECEPTOR IN VASCULAR LESION FORMATION TRANSFER APPROACH, Journal of investigative medicine, 46(1), 1998, pp. 91-91
Citation: Rs. Poston et al., PREVENTION OF ISCHEMICALLY INDUCED NEOINTIMAL HYPERPLASIA USING EX-VIVO ANTISENSE OLIGODEOXYNUCLEOTIDES, The Journal of heart and lung transplantation, 17(4), 1998, pp. 349-355
Authors:
SAYEEDSHAH U
MANN MJ
GRACHEV S
REUL R
FERZOCO SJ
LAURENCE R
DZAU VJ
COHN LH
Citation: U. Sayeedshah et al., NONVIRAL GENE-TRANSFER IN PORCINE MYOCARDIUM ENHANCED BY TRANSMYOCARDIAL LASER REVASCULARIZATION, Journal of the American College of Cardiology, 31(2), 1998, pp. 3-3
Authors:
TOMITA N
HORIUCHI M
TOMITA S
GIBBONS GH
KIM JYS
BARAN D
DZAU VJ
Citation: N. Tomita et al., AN OLIGONUCLEOTIDE DECOY FOR TRANSCRIPTION FACTOR E2F INHIBITS MESANGIAL CELL-PROLIFERATION IN-VITRO, American journal of physiology. Renal, fluid and electrolyte physiology, 44(2), 1998, pp. 278-284
Authors:
LEHTONEN JYA
LAURENT D
HORIUCHI M
DZAU VJ
Citation: Jya. Lehtonen et al., CERAMIDE AS A 2ND-MESSENGER FOR ANGIOTENSIN-II TYPE-2 RECEPTOR-MEDIATED APOPTOSIS, Journal of hypertension, 16, 1998, pp. 94-94
Citation: Yqe. Chen et al., CLONING AND IDENTIFICATION OF A NOVEL REPRESSOR TRANSCRIPTIONAL FACTOR INHIBITING RENIN GENE-EXPRESSION, Hypertension, 32(3), 1998, pp. 41-41
Authors:
MASAKI H
KURIHARA T
YAMAKI A
INOMATA N
NOZAWA Y
MORI Y
MURASAWA S
KIZIMA K
MARUYAMA K
HORIUCHI M
DZAU VJ
TAKAHASHI H
IWASAKA T
INADA M
MATSUBARA H
Citation: H. Masaki et al., CARDIAC-SPECIFIC OVEREXPRESSION OF ANGIOTENSIN-II AT2 RECEPTOR CAUSESATTENUATED RESPONSE TO AT1 RECEPTOR-MEDIATED PRESSOR AND CHRONOTROPICEFFECTS, The Journal of clinical investigation, 101(3), 1998, pp. 527-535
Citation: Vj. Dzau et M. Horiuchi, VASCULAR REMODELING - THE EMERGING PARADIGM OF PROGRAMMED CELL-DEATH (APOPTOSIS) - THE FRANCIS-B-PARKER-LECTURESHIP, Chest, 114(1), 1998, pp. 91-99
Authors:
MANN MJ
WHITTEMORE AD
DONALDSON MC
BELKIN MA
CONTE MS
ORAV J
POLAK JF
DZAU VJ
Citation: Mj. Mann et al., THE PREVENT TRIAL OF VEIN GRAFT GENETIC-ENGINEERING - PRELIMINARY MOLECULAR AND CLINICAL FINDINGS, Circulation, 98(17), 1998, pp. 1683-1683
Citation: M. Akishita et al., ANGIOTENSIN-II TYPE-2 RECEPTOR SETS THE LEVEL OF ERK ACTIVITY AND INFLUENCES FETAL VASCULAR GROWTH, Circulation, 98(17), 1998, pp. 1732-1732
Citation: Yqe. Chen et al., CLONING AND CHARACTERIZATION OF A NOVEL TRANSCRIPTIONAL FACTOR REPRESSING RENIN GENE-EXPRESSION, Circulation, 98(17), 1998, pp. 2473-2473
Authors:
BRAUNDULLAEUS RC
MANN MJ
VONDERLEYEN HE
DZAU VJ
Citation: Rc. Braundullaeus et al., ROLE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27(KIP1)IN MEDIATING VASCULAR SMOOTH-MUSCLE CELL HYPERTROPHY, Circulation, 98(17), 1998, pp. 3145-3145
Authors:
BRAUNDULLAEUS RC
MANN MJ
VONDERLEYEN HE
DZAU VJ
Citation: Rc. Braundullaeus et al., CELL-CYCLE DEPENDENT MODULATION OF VCAM-1 EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS IS TRANSCRIPTIONALLY REGULATED THROUGH IRF-1, Circulation, 98(17), 1998, pp. 3152-3152
Authors:
DAVIET L
HORIUCHI M
HAYASHIDA W
LEHTONEN JYA
BISHOPRIC NH
DZAU VJ
Citation: L. Daviet et al., ANTAGONISTIC ACTIONS OF TYPE-1 AND TYPE-2 ANGIOTENSIN-II RECEPTORS ONRAT CARDIOMYOCYTE APOPTOSIS, Circulation, 98(17), 1998, pp. 3885-3885
Authors:
ZANG J
ING D
DZAU VJ
WEBSTER KA
BISHOPRIC NH
Citation: J. Zang et al., NITRIC-OXIDE ACTIVATIONS OF CARDIOMYOCYTE APOPTOSIS, MAPK ERK AND JUNKINASES EXHIBIT DIFFERENTIAL DOSE-DEPENDENCE AND CGMP SENSITIVITY/, Circulation, 98(17), 1998, pp. 3894-3894
Citation: L. Daviet et al., ATRAP, A NOVEL PROTEIN THAT INTERACTS WITH THE C-TERMINAL CYTOPLASMICDOMAIN OF THE ANGIOTENSIN-II TYPE-1 RECEPTOR, Circulation, 98(17), 1998, pp. 3912-3912